Eisai
4523.T
$55.90
Share price
-0.73%
Change (1 day)
25.62%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Eisai (4523.T) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $3.02 B
According to Eisai's latest financial reports the company's total liabilities are $3.02 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Eisai - Total liabilities on balance sheet (from 2009 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-03-31 | $3.83 B | 16.79% |
| 2021-03-31 | $3.28 B | -1.36% |
| 2020-03-31 | $3.32 B | -11.96% |
| 2019-03-31 | $3.77 B | -7.61% |
| 2018-03-31 | $4.09 B | 6.8% |
| 2017-03-31 | $3.83 B | 8.38% |
| 2016-03-31 | $3.53 B | -6.1% |
| 2015-03-31 | $3.76 B | -10.88% |
| 2014-03-31 | $4.22 B | -22.82% |
| 2013-03-31 | $5.47 B | -21.98% |
| 2012-03-31 | $7.01 B | -8.29% |
| 2011-03-31 | $7.64 B | 5.15% |
| 2010-03-31 | $7.27 B | 0.66% |
| 2009-03-31 | $7.22 B | 7.66% |
| 2008-03-31 | $6.71 B | 244.51% |
| 2007-03-31 | $1.94 B | 0.61% |
| 2006-03-31 | $1.93 B | 2.14% |
| 2005-03-31 | $1.89 B | 0.63% |
| 2004-03-31 | $1.88 B | 14.51% |
| 2003-03-31 | $1.64 B | 12.15% |
| 2002-03-31 | $1.46 B | -4.45% |
| 2001-03-31 | $1.53 B |